Navigating the GLP-1 Boom: Clinical Strategy and Industry Insights
The pharmaceutical industry is increasingly driven by GLP-1 obesity therapies, reshaping clinical practice, formulary strategies, biologic innovation, and precision medicine across multiple specialties.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.